language:
Find link is a tool written by Edward Betts.searching for ERCC1 24 found (72 total)
alternate case: eRCC1
Triple-stranded DNA
(6,098 words)
[view diff]
exact match in snippet
view article
find links to article
deficient in ERCC1-XPF and ERCC1-XPG, these deletions were less prevalent near H-DNA forming sequences. Additionally, more mutations were found in ERCC1-XPF andTransverse colon (373 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisAscending colon (473 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisOrlando D. Schärer (1,149 words) [view diff] exact match in snippet view article find links to article
interstrand crosslink repair and structure-specific nucleases, such as ERCC1-XPF and XPG. 2016: Excellence in Senior Research Award, Stony Brook UniversityLaura Niedernhofer (1,677 words) [view diff] exact match in snippet view article find links to article
Bernhard; Mann, Matthias; Hoeijmakers, Jan H.J; De Lange, Titia (2003). "ERCC1/XPF Removes the 3′ Overhang from Uncapped Telomeres and Represses FormationDescending colon (747 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisCecum (1,530 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisIntestinal gland (1,652 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisXRCC1 (2,856 words) [view diff] exact match in snippet view article find links to article
Kim YT, Jheon S, Sung SW, Kim JH (2010). "The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-smallTelomere-binding protein (1,658 words) [view diff] exact match in snippet view article find links to article
observed. However, this requires the work of excision repair exonuclease ERCC1/XPF so inhibition of TERF2 alone may not necessarily lead to immediate shorteningOrganomegaly (1,227 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisCD3EAP (592 words) [view diff] exact match in snippet view article find links to article
Skjelbred CF, Saebø M, Nexø BA, et al. (2006). "Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a caseBowel obstruction (3,105 words) [view diff] exact match in snippet view article find links to article
Ramsey L, Hassounah N, Taylor H, et al. (July 2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". JournalSophie Postel-Vinay (538 words) [view diff] exact match in snippet view article find links to article
titled Synthetic lethality and functional study of DNA repair defects in ERCC1-deficient non-small-cell lung cancer, in December 2016. Her research wasRestriction modification system (2,668 words) [view diff] exact match in snippet view article find links to article
PMC 2626626. PMID 18724932. Gasior SL, Roy-Engel AM, Deininger PL (2008). "ERCC1/XPF limits L1 retrotransposition". DNA Repair. 7 (6): 983–989. doi:10.1016/jPPP1R13L (855 words) [view diff] exact match in snippet view article find links to article
Hansteen IL, Vogel U, Kure EH (July 2006). "Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a caseStephen C. West (1,292 words) [view diff] exact match in snippet view article find links to article
human cells involving BLM-topoIIIα-RMI1-RMI2 (BTR), SLX1-SLX4-MUS81-EME1-ERCC1-XPF (SMX) and GEN1. His laboratory discovered that the Holliday junctionRestriction enzyme (5,853 words) [view diff] exact match in snippet view article find links to article
PMC 2626626. PMID 18724932. Gasior SL, Roy-Engel AM, Deininger PL (June 2008). "ERCC1/XPF limits L1 retrotransposition". DNA Repair. 7 (6): 983–9. doi:10.1016/jLarge intestine (5,661 words) [view diff] exact match in snippet view article find links to article
Goldschmid S, Banerjee B, Perini RF, Bernstein C (2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". J VisTERF2IP (1,161 words) [view diff] exact match in snippet view article find links to article
Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T (December 2003). "ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formationBRCA1 (13,568 words) [view diff] exact match in snippet view article find links to article
Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, et al. (April 2012). "ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict theMethylated-DNA-protein-cysteine methyltransferase (3,857 words) [view diff] exact match in snippet view article find links to article
repair genes evaluated, 13 DNA repair genes, MGMT, NTHL1, OGG1, SMUG1, ERCC1, ERCC2, ERCC3, ERCC4, MLH1, MLH3, RAD50, XRCC4 and XRCC5 were all significantlyColorectal cancer (15,927 words) [view diff] exact match in snippet view article find links to article
Ramsey L, Hassounah N, Taylor H, et al. (July 2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". JournalKAT5 (2,956 words) [view diff] exact match in snippet view article find links to article
Brambilla E, Eymin B, Gazzeri S (Feb 2012). "Activation of a Tip60/E2F1/ERCC1 network in human lung adenocarcinoma cells exposed to cisplatin". Carcinogenesis